Literature DB >> 23353794

Surgery results in exaggerated and persistent cognitive decline in a rat model of the Metabolic Syndrome.

Xiaomei Feng1, Vincent Degos, Lauren G Koch, Steven L Britton, Yinggang Zhu, Susana Vacas, Niccolò Terrando, Jeffrey Nelson, Xiao Su, Mervyn Maze.   

Abstract

BACKGROUND: Postoperative cognitive decline can be reproduced in animal models. In a well-validated rat model of the Metabolic Syndrome, we sought to investigate whether surgery induced a more severe and persistent form of cognitive decline similar to that noted in preliminary clinical studies.
METHODS: In rats that had been selectively bred for low and high exercise endurance, the low capacity runners (LCR) exhibited features of Metabolic Syndrome (obesity, dyslipidemia, insulin resistance, and hypertension). Tibial fracture surgery was performed under isoflurane anesthesia in LCR and high capacity runner (HCR) rats and cognitive function was assessed postoperatively in a trace-fear conditioning paradigm and Morris Water Maze; non-operated rats were exposed to anesthesia and analgesia (sham). Group sizes were n = 6.
RESULTS: On postoperative D7, LCR rats had shorter freezing times than postoperative HCR rats. Five months postoperatively, LCR rats had a flatter learning trajectory and took longer to locate the submerged platform than postoperative HCR rats; dwell-time in the target quadrant in a probe trial was shorter in the postoperative LCR compared to HCR rats. LCR and HCR sham rats did not differ in any test.
CONCLUSION: Postoperatively, LCR rats diverged from HCR rats exhibiting a greater decline in memory, acutely, with persistent learning and memory decline, remotely; this could not be attributed to changes in locomotor or swimming performance. This Metabolic Syndrome animal model of surgery-induced cognitive decline corroborates, with high fidelity, preliminary findings of postoperative cognitive dysfunction in Metabolic Syndrome patients.

Entities:  

Mesh:

Year:  2013        PMID: 23353794      PMCID: PMC5530762          DOI: 10.1097/ALN.0b013e318286d0c9

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  36 in total

Review 1.  Cognitive and neurologic outcomes after coronary-artery bypass surgery.

Authors:  Ola A Selnes; Rebecca F Gottesman; Maura A Grega; William A Baumgartner; Scott L Zeger; Guy M McKhann
Journal:  N Engl J Med       Date:  2012-01-19       Impact factor: 91.245

Review 2.  Adiponectin receptor binding proteins--recent advances in elucidating adiponectin signalling pathways.

Authors:  Christa Buechler; Josef Wanninger; Markus Neumeier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

3.  Epistasis and the release of genetic variation during long-term selection.

Authors:  Orjan Carlborg; Lina Jacobsson; Per Ahgren; Paul Siegel; Leif Andersson
Journal:  Nat Genet       Date:  2006-03-12       Impact factor: 38.330

4.  Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline.

Authors:  Niccolò Terrando; Claudia Monaco; Daqing Ma; Brian M J Foxwell; Marc Feldmann; Mervyn Maze
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

5.  Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity.

Authors:  Colleen M Novak; Carlos Escande; Paul R Burghardt; Minzhi Zhang; Maria Teresa Barbosa; Eduardo N Chini; Steven L Britton; Lauren G Koch; Huda Akil; James A Levine
Journal:  Horm Behav       Date:  2010-03-27       Impact factor: 3.587

6.  Postoperative cognitive dysfunction after noncardiac surgery: effects of metabolic syndrome.

Authors:  Judith A Hudetz; Kathleen M Patterson; Oludara Amole; Aaron V Riley; Paul S Pagel
Journal:  J Anesth       Date:  2011-04-23       Impact factor: 2.078

7.  The cost of delirium in the surgical patient.

Authors:  K Franco; D Litaker; J Locala; D Bronson
Journal:  Psychosomatics       Date:  2001 Jan-Feb       Impact factor: 2.386

8.  Long-term consequences of postoperative cognitive dysfunction.

Authors:  Jacob Steinmetz; Karl Bang Christensen; Thomas Lund; Nicolai Lohse; Lars S Rasmussen
Journal:  Anesthesiology       Date:  2009-03       Impact factor: 7.892

9.  Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting.

Authors:  Kan Kajimoto; Katsumi Miyauchi; Takatoshi Kasai; Naotake Yanagisawa; Taira Yamamoto; Keita Kikuchi; Takeshi Nakatomi; Hiroshi Iwamura; Hiroyuki Daida; Atsushi Amano
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03       Impact factor: 5.209

10.  Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance.

Authors:  Robert C Noland; John P Thyfault; Sarah T Henes; Brian R Whitfield; Tracey L Woodlief; Jasper R Evans; Jennifer A Lust; Steven L Britton; Lauren G Koch; Ronald W Dudek; G Lynis Dohm; Ronald N Cortright; Robert M Lust
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-06       Impact factor: 4.310

View more
  36 in total

Review 1.  Postoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the Elderly.

Authors:  Miles Berger; Jacob W Nadler; Jeffrey Browndyke; Niccolo Terrando; Vikram Ponnusamy; Harvey Jay Cohen; Heather E Whitson; Joseph P Mathew
Journal:  Anesthesiol Clin       Date:  2015-07-16

2.  Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice.

Authors:  Xiaomei Feng; Martin Valdearcos; Yosuke Uchida; David Lutrin; Mervyn Maze; Suneil K Koliwad
Journal:  JCI Insight       Date:  2017-04-06

3.  CORR Insights®: Hospital for special surgery pediatric functional activity brief scale predicts physical fitness testing performance.

Authors:  Timothy E Cooney
Journal:  Clin Orthop Relat Res       Date:  2014-03-26       Impact factor: 4.176

4.  Resting-State Functional Connectivity and Cognition After Major Cardiac Surgery in Older Adults without Preoperative Cognitive Impairment: Preliminary Findings.

Authors:  Jeffrey N Browndyke; Miles Berger; Todd B Harshbarger; Patrick J Smith; William White; Tiffany L Bisanar; John H Alexander; Jeffrey G Gaca; Kathleen Welsh-Bohmer; Mark F Newman; Joseph P Mathew
Journal:  J Am Geriatr Soc       Date:  2016-11-17       Impact factor: 5.562

5.  Higher Circulating Trimethylamine N-oxide Sensitizes Sevoflurane-Induced Cognitive Dysfunction in Aged Rats Probably by Downregulating Hippocampal Methionine Sulfoxide Reductase A.

Authors:  Liang Zhao; Chuanyang Zhang; Guilin Cao; Xueyi Dong; Dongliang Li; Lei Jiang
Journal:  Neurochem Res       Date:  2019-09-04       Impact factor: 3.996

6.  Dexmedetomidine Prevents Cognitive Decline by Enhancing Resolution of High Mobility Group Box 1 Protein-induced Inflammation through a Vagomimetic Action in Mice.

Authors:  Jun Hu; Susana Vacas; Xiaomei Feng; David Lutrin; Yosuke Uchida; Ieng Kit Lai; Mervyn Maze
Journal:  Anesthesiology       Date:  2018-05       Impact factor: 7.892

7.  Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome.

Authors:  Xiao Su; Xiaomei Feng; Niccolo Terrando; Yan Yan; Ajay Chawla; Lauren G Koch; Steven L Britton; Michael A Matthay; Mervyn Maze
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

8.  Eszopiclone and dexmedetomidine depress ventilation in obese rats with features of metabolic syndrome.

Authors:  William A Filbey; David T Sanford; Helen A Baghdoyan; Lauren G Koch; Steven L Britton; Ralph Lydic
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

Review 9.  Neurocognitive Adverse Effects of Anesthesia in Adults and Children: Gaps in Knowledge.

Authors:  Christopher G Ward; Roderic G Eckenhoff
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

Review 10.  The neuroinflammatory response of postoperative cognitive decline.

Authors:  Susana Vacas; Vincent Degos; Xiaomei Feng; Mervyn Maze
Journal:  Br Med Bull       Date:  2013-04-04       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.